ANNOUNCING HEXO CORP. AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON
Cannabis Europa is excited to announce HEXO as a bronze partner for our London conference this June at Southbank Centre.
HEXO Corp is an award-winning Canadian medical and adult-use cannabis company and home to Elixir CBD – winner of Innovation of the Year and Cannabis Product of the Year (2018 Canadian Cannabis Awards).
Cannabis Europa is proud to welcome HEXO to the conversation about growing the European cannabis industry. HEXO’s innovation and stellar business capability have resulted in partnerships with traditional sectors, helping to bring cannabis into the mainstream.
In March this year, HEXO became the first cannabis company to join Food & Consumer Products of Canada (FCPC), an established and industry-leading association in the consumer-packaged goods space. As one of the largest licensed cannabis companies in Canada, HEXO operates with 1.8 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre.
Through its HEXO brand, the company is renowned for product innovations in smoke-free cannabis and exceptional customer service. HEXO presents the innovative product line ‘Decarb’, in the form of cannabis powder that can be consumed as a supplement to food and beverages. In the world of cannabis, decarboxylation is a process that activates THC and CBD, resulting in fine-milled, activated cannabis powder that is ready to consume in food, beverages or in capsules.
With a booming European consumer demand, Cannabis Europa in June will gather industry leaders to discuss the future regulatory environment and how to ensure that European consumers can access high-quality products. We will not only touch upon questions about the EU’s Novel Foods Regulations on CBD relating to foods and food supplements, but also broader questions of how shifting perceptions towards cannabis are changing the way we view healthcare and wellness.
Join us on June 24th-25th in London and help shape the future of medical cannabis in Europe. Learn more here.